TY  - GEN
AU  - Piek,Arnold
AU  - Koonen,Debby P Y
AU  - Schouten,Elisabeth-Maria
AU  - Lindtstedt,Eva L
AU  - Michaëlsson,Erik
AU  - de Boer,Rudolf A
AU  - Silljé,Herman H W
TI  - Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling
SN  - 2045-2322
PY  - 2020///1111
KW  - Angiotensin II
KW  - administration & dosage
KW  - Animals
KW  - Diet, High-Fat
KW  - adverse effects
KW  - Disease Models, Animal
KW  - Heart Ventricles
KW  - drug effects
KW  - Humans
KW  - Hypertension
KW  - blood
KW  - Hypertrophy, Left Ventricular
KW  - Intra-Abdominal Fat
KW  - Liver
KW  - Male
KW  - Mice
KW  - Non-alcoholic Fatty Liver Disease
KW  - Obesity
KW  - Peroxidase
KW  - antagonists & inhibitors
KW  - Severity of Illness Index
KW  - Thioxanthenes
KW  - Ventricular Remodeling
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41598-019-55263-y
ER  -